-
InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update
19 Dec 2025 17:29 GMT
… reports financial results for its first quarter of fiscal year 2026, … :
BayMedica commercial business generated revenues of $1.1 million … ,962
771,225
Gross profit
403,159
493,413 …
About InMed
InMed Pharmaceuticals is a pharmaceutical drug development company …
-
PetMed: Fiscal Q1 Earnings Snapshot
19 Dec 2025 22:06 GMT
… .2 million in its fiscal first quarter.
The Delray Beach, Florida-based … per share.
The pet pharmacy company posted revenue of $51.2 million …
-
Amesite introduces AI-native EMR system, NurseMagic EMR
22 Dec 2025 14:08 GMT
Amesite has announced the introduction of NurseMagic EMR, an AI-native electronic medical record (EMR) system, for the post-acute care sector.
The system extends the company’s NurseMagic platform from a point-of-care solution to an enterprise-level …
-
BioMarin makes its largest-ever transaction, paying $4.8B for fellow rare disease drugmaker Amicus
19 Dec 2025 18:29 GMT
… deal will accelerate BioMarin’s revenue growth immediately upon close, … soon face competition from Ascendis Pharma';s TransCon CNP, … an FDA decision in the first quarter of next year.
In a … of the year after the drugmaker gained Inozyme for $270 million …
-
Accenture plc (NYSE:ACN) Q1 2026 Earnings Call Transcript
19 Dec 2025 13:08 GMT
… growth of 10% compared to Q1 last year. We continue to … very pleased with our first quarter results with revenue at the top of … grid and utilities, right, the pharma and R&D.
But … about is that our contract profitability, we’re starting to see …
-
UnitedHealth commits to changes after independent review
22 Dec 2025 18:53 GMT
… industry in order to inflate profits, as some critics allege. … approval processes, and how pharmacy benefit manager Optum Rx passes … its HouseCalls program in the first quarter. Critics slam HouseCalls, in … more of the savings as profit.
The Analysis Group’s …
-
Jabil Inc. (NYSE:JBL) Q1 2026 Earnings Call Transcript
18 Dec 2025 13:07 GMT
… through our numbers. Net revenue for Q1 was $8.3 billion … , the first quarter was better than expected in both revenue and core … our priorities remain the same: profitable growth, diversified mix, margin … added a capability on pharma sort of filling up …
-
Vivos Inc Summarzes Preogress in its Animal Therapy Division
22 Dec 2025 13:30 GMT
Kennewick, WA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) The IsoPet division reported an 800% year-over-year increase in administered therapies from 2024 to 2025, reflecting accelerating veterinary adoption nationwide. In recent months, …
-
BioSpace Editors’ Top 5 Biggest News Stories of the Year
22 Dec 2025 13:12 GMT
… On October 30, the Danish pharma, desperate to replenish a flagging … unprecedented.” The New York pharma quickly filed litigation against Novo … the Huntington’s-focused non-profit Factor-H, cautioned against … of AMT-130 in the first quarter of 2026, with a …
-
102-year-old grocery chain shuts key locations, no bankruptcy
21 Dec 2025 09:05 GMT
… , which can decrease grocery company revenue and profits. Economically challenged grocery chains … by the end of the first quarter of 2026, the company said … , Pa., operates 190 stores, 133 pharmacies, 107 fuel stations, and over …